Mezzanine Management backs Optimapharm with €10m

Mezzanine Management drew capital from the €250m vehicle AMC IV. The deal is Mezzanine Management's first in Croatia.

With the backing of Mezzanine Management, the company is looking to grow by acquiring complementary businesses in CEE to consolidate the regional market and also to expand its presence in western Europe.   

Optimapharm is the fund's fourth investment after ATM, Netrisk and Nettle.

Company
Founded in 2003 and headquartered in Donja Lomnica, Croatia, Optimapharm organises, monitors and controls clinical trials of new drugs for clients in the pharmaceutical, biotechnology and medical device sectors. The business is headquartered in Donja Lomnica and operates a total of 13 offices in cities across Europe, including Cambridge and Antwerp. 

People
Mezzanine Management – Chris Buckle (managing partner).

Advisers
Equity – KPMG Croatia (financial due diligence, tax); Wolf Theiss (legal).
Company – Provectus Capital (M&A); Buterin & Posavec (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• CEE
• Healthcare
• Croatia
• CEE healthcare
• Mezzanine